Edition:
United States

Tocagen Inc (TOCA.OQ)

TOCA.OQ on NASDAQ Stock Exchange Global Select Market

13.80USD
2:50pm EDT
Change (% chg)

$0.27 (+2.00%)
Prev Close
$13.53
Open
$13.55
Day's High
$13.82
Day's Low
$13.10
Volume
99,119
Avg. Vol
41,075
52-wk High
$14.49
52-wk Low
$7.52

Chart for

About

Tocagen Inc. (Tocagen) is a clinical-stage, cancer-selective gene therapy company. The Company is focused on developing product candidates designed to activate a patient’s immune system against their own cancer. Its cancer-selective gene therapy platform is built on retroviral replicating vectors (RRVs), which are designed to... (more)

Overall

Beta: --
Market Cap(Mil.): $269.94
Shares Outstanding(Mil.): 19.95
Dividend: --
Yield (%): --

Financials

  TOCA.OQ Industry Sector
P/E (TTM): -- 108.45 32.71
EPS (TTM): -2.50 -- --
ROI: -58.85 1.54 12.72
ROE: -73.91 0.30 14.84

BRIEF-Tocagen Entered Amended And Restated Loan And Security Agreement For $26.5 Mln

* TOCAGEN - ENTERED AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT FOR $26.5 MILLION AS TERM LOANS FUNDED ON EFFECTIVE DATE - SEC FILING Source text: (https://bit.ly/2IEQjX8) Further company coverage:

May 23 2018

BRIEF-Tocagen Reports Q1 Loss Per Share $0.65

* TOCAGEN REPORTS FIRST QUARTER 2018 FINANCIAL AND BUSINESS RESULTS

May 10 2018

BRIEF-Tocagen And ApolloBio Enter License Agreement To Develop Toca 511 & Toca FC In Greater China

* TOCAGEN AND APOLLOBIO ENTER LICENSE AGREEMENT TO DEVELOP AND COMMERCIALIZE TOCA 511 & TOCA FC IN THE GREATER CHINA REGION

Apr 19 2018

Competitors

Earnings vs. Estimates